Evidence supporting the use of: Resveratrol
For the health condition: Strokes

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Resveratrol, a polyphenolic compound found in grapes, red wine, and certain berries, has been investigated for its potential neuroprotective effects, including in the context of stroke. Preclinical studies, primarily in animal models, have demonstrated that resveratrol may reduce brain damage following ischemic stroke by modulating oxidative stress, inflammation, and apoptosis pathways. The mechanisms proposed include activation of SIRT1 (a sirtuin-related protein involved in cellular stress resistance), reduction of reactive oxygen species (ROS), and inhibition of inflammatory mediators that contribute to neuronal injury after stroke.

However, evidence in humans is limited. Most clinical data involve observational studies or small pilot trials, and robust, large-scale randomized controlled trials (RCTs) specifically evaluating resveratrol for stroke prevention or treatment are lacking. Some studies suggest that resveratrol may improve vascular function and reduce risk factors (e.g., hypertension, hyperlipidemia), which could indirectly lower the risk of stroke, but direct evidence for its efficacy in acute stroke treatment or secondary prevention is not established. Safety at supplemental doses appears reasonable in short-term studies, but efficacy remains unproven.

In summary, while there is a scientific rationale and promising preclinical data, clinical validation is weak, and resveratrol cannot currently be recommended as a proven treatment for stroke. Further research, particularly well-controlled human trials, is necessary to clarify its role.

More about resveratrol
More about Strokes